title: Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET).
abstract: OBJECTIVE
  Changes in hemostasis after off-pump coronary artery bypass grafting are still being discussed. There is a lack of information about platelet activity and aspirin efficacy after coronary artery bypass grafting. The aim of this study was to assess and compare platelet activity and aspirin efficacy early and late after off-pump and on-pump coronary artery bypass grafting.
  
  
  METHODS
  Eighty patients were enrolled in a prospective randomized study. Platelet activity was determined based on membrane expression of antigen CD62P (P-selectin) by means of flow cytometric analysis. Aspirin efficacy was assessed by using arachidonic acid-induced platelet aggregation. Blood samples were collected before the operation, immediately postoperatively, and on days 1, 2, 5, and 30.
  
  
  RESULTS
  In the off-pump group expression of P-selectin was markedly increased in comparison with preoperative values, with a maximum difference observed on day 2 (+53%, P = .02), and it was significantly higher compared with that seen in the on-pump group on days 2 and 5 (+53% vs +4%, P = .004, and +20% vs -16%, P = .005). On day 30, P-selectin expression was similar both between the groups and in comparison with the preoperative values. Arachidonic acid-induced platelet aggregation was gradually decreasing until day 30, but on day 2, there was an unexpected increase in aggregation that was more expressed in the off-pump group.
  
  
  CONCLUSIONS
  The platelet activity is higher in the early postoperative period in off-pump compared with on-pump coronary artery bypass grafting. The present aspirin strategy seems to be insufficient in the early postoperative period, irrespective of the surgical technique used.
authors.affiliation: Department of Cardiac Surgery, 3rd Medical School, Cardiocenter, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic. fandabednar@email.cz
authors.forename: Frantisek
authors.initials: F
authors.lastname: Bednar
authors.forename: Pavel
authors.initials: P
authors.lastname: Osmancik
authors.forename: Tomas
authors.initials: T
authors.lastname: Vanek
authors.forename: Heidi
authors.initials: H
authors.lastname: Mocikova
authors.forename: Martin
authors.initials: M
authors.lastname: Jares
authors.forename: Zbynek
authors.initials: Z
authors.lastname: Straka
authors.forename: Petr
authors.initials: P
authors.lastname: Widimsky
mesh_terms: D000368:Aged; D001241:Aspirin / Q000008:administration & dosage*; D016001:Confidence Intervals; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods*; D047549:Coronary Artery Bypass, Off-Pump / Q000009:adverse effects / Q000379:methods; D023921:Coronary Stenosis / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000032:analysis*; D015539:Platelet Activation / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology; D010976:Platelet Count; D011182:Postoperative Care; D011300:Preoperative Care; D011336:Probability; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D016019:Survival Analysis; D013925:Thromboplastin / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D019007:P-Selectin; D013925:Thromboplastin; D001241:Aspirin